Subodh Verma


Scientist, Keenan Research Centre for Biomedical Science


Dr. Subodh Verma is a cardiac surgeon-scientist at St. Michael’s Hospital, Professor at the University of Toronto and the Canada Research Chair in Atherosclerosis. He has been on the India Abroad Power List, recognized as one of Canada’s Top 40 under 40, and honoured with the Howard Morgan Award from the International Academy of Cardiovascular Sciences and the Royal College of Physicians and Surgeons of Canada Gold Medal in Surgery. He is a member of the Royal Society of Canada College of New Scholars, Artists and Scientists, and an inductee of the American Association of Thoracic Surgeons. Dr. Verma runs a practice that encompasses the entire spectrum of adult cardiac surgery (with a special interest in mitral valve repair and bicuspid aortopathy).

He is involved in several clinical trials and oversees a dynamic pre-clinical research laboratory that focuses on the roles of risk factors, inflammation and autophagy in cardiovascular health. His innovative research has culminated in nearly 300 peer-reviewed papers and two United States patents. Dr. Verma’s meta-analysis revealing that bypass surgery is superior to angioplasty in patients with diabetes has been used by the American College of Cardiology and the Canadian Cardiovascular Society (CCS) to shape the recommendations around the best clinical choice for revascularization procedures involving individuals with diabetes. He has contributed to the CCS guidelines for antiplatelet therapy, atrial fibrillation, dyslipidemia, peripheral arterial disease, and stable coronary artery disease; Canadian Cardiovascular Surgery Position Statement and Canadian Cardiometabolic Risk Position Paper. Dr. Verma spearheads the CARDIOLINK platform that will conduct clinical trials in atrial fibrillation, aneurysm and cerebral protection, diabetes and secondary prevention, valvular heart disease, and critical limb ischemia. He (co-)founded and (co-)chairs many regional and national educational initiatives that include the Landmark Lecture, State of the Heart Symposium, Toronto Acute Coronary Syndrome Summit, St. Michael’s Heart Valve Summit, Advances in Cardiology, Current Issues in Cardiology, and At the Heart of Diabetes programs.


Recent Publications

  1. Verma, S, Mazer, CD, Al-Omran, M, Inzucchi, SE, Fitchett, D, Hehnke, U et al.. Cardiovascular Outcomes and Safety of Empagliflozin in Patients With Type 2 Diabetes Mellitus and Peripheral Artery Disease: A Subanalysis of EMPA-REG OUTCOME. Circulation. 2017; :. doi: 10.1161/CIRCULATIONAHA.117.032031. PubMed PMID:29133602 .
  2. Mazer, CD, Whitlock, RP, Fergusson, DA, Hall, J, Belley-Cote, E, Connolly, K et al.. Restrictive or Liberal Red-Cell Transfusion for Cardiac Surgery. N. Engl. J. Med. 2017; :. doi: 10.1056/NEJMoa1711818. PubMed PMID:29130845 .
  3. Maredia, AK, Greenway, SC, Verma, S, Fedak, PWM. Bicuspid aortic valve-associated aortopathy: update on biomarkers. Curr. Opin. Cardiol. 2017; :. doi: 10.1097/HCO.0000000000000481. PubMed PMID:29095713 .
  4. Makanjee, B, Galiwango, P, Verma, S, Yanagawa, B. Electrophysiology Study and Catheter Ablation With Superior Vena Cava Stump. J Invasive Cardiol. 2017;29 (11):E166. . PubMed PMID:29086736 .
  5. Verma, S, Leiter, LA, Bhatt, DL. CANTOS Ushers in a New Calculus of Inflammasome Targeting for Vascular Protection-and Maybe More. Cell Metab. 2017;26 (5):703-705. doi: 10.1016/j.cmet.2017.09.022. PubMed PMID:29056511 .
  6. Swaminathan, M, Stafford-Smith, M, Chertow, GM, Warnock, DG, Paragamian, V, Brenner, RM et al.. Allogeneic Mesenchymal Stem Cells for Treatment of AKI after Cardiac Surgery. J. Am. Soc. Nephrol. 2017; :. doi: 10.1681/ASN.2016101150. PubMed PMID:29038286 .
  7. Mazine, A, Friedrich, JO, Nedadur, R, Verma, S, Ouzounian, M, Jüni, P et al.. Systematic review and meta-analysis of chordal replacement versus leaflet resection for posterior mitral leaflet prolapse. J. Thorac. Cardiovasc. Surg. 2017; :. doi: 10.1016/j.jtcvs.2017.07.078. PubMed PMID:28967416 .
  8. Zhu, YM, Verma, S, Fung, M, McQueen, MJ, Anderson, TJ, Lonn, EM et al.. Association of Apolipoproteins B and A-1 With Markers of Vascular Health or Cardiovascular Events. Can J Cardiol. 2017;33 (10):1305-1311. doi: 10.1016/j.cjca.2017.08.004. PubMed PMID:28941609 .
  9. Ruel, M, Verma, S, Bhatt, DL. What Is the Optimal Revascularization Strategy for Left Main Coronary Stenosis?. JAMA Cardiol. 2017;2 (10):1061-1062. doi: 10.1001/jamacardio.2017.2946. PubMed PMID:28903135 .
  10. Yanagawa, B, Verma, S, Mazer, CD. Subclinical Valve Thrombosis in Sutureless Bioprosthetic Valves. J Am Heart Assoc. 2017;6 (8):. doi: 10.1161/JAHA.117.006862. PubMed PMID:28862965 PubMed Central PMC5586480.
Search PubMed

Affiliations & Other Activities

  • Staff Surgeon, Division of Cardiology , St. Michael’s Hospital
  • Professor, Department of Surgery and Pharmacology & Toxicology, University of Toronto